GeoVax

Industry: HIV vaccines

Biotech company specializing in developing and commercializing human vaccines to combat HIV/AIDS. Designed for predominant AIDS virus subtypes using DNA and viral vector technologies, GeoVax's AIDS vaccine technology is designed for use in uninfected people to protect them from AIDS should they be exposed to the HIV-1 virus. Preventive vaccine recently completed Phase 2 safety trials.

Company website: GeoVax

Back to companies

191 Peachtree Street, NE, Suite 849  |  Atlanta, Georgia 30303  |  404.332.9770  |  Directions  |  Privacy  |  GRA Venture Fund, LLC
Copyright © Georgia Research Alliance  |  All Rights Reserved